+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)

Archives

Loading Events

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis

This presentation discusses the key screening tools and diagnostic algorithms associated with autosomal dominant polycystic kidney disease (ADPKD), including risk assessment tools to assess for rapid progression.

Location

Perry’s Steakhouse & Grille – River Oaks

1997 West Gray St
Houston, Texas 77019 United States
+ Google Map
346.293.8402 View Venue Website

Featured Speakers

Biruh T Workeneh

Biruh T Workeneh, MD, FASN

Associate Professor, Department of Emergency Medicine, Division of Internal Medicine

The University of Texas MD Anderson Cancer Center*

Dr Biruh Workeneh is a provider in the MD Anderson Internal Medicine Center and an Associate Professor in the Section of Nephrology. He is board-certified in Internal Medicine and joined MD Anderson in 2015.

Molly Jansen

Molly Jansen, PhD

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Dr Molly Jansen is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.

*Dr Workeneh is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Jansen is an employee of OPDC.

Registration

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.